Education
About Us
Working with TipRanks
Follow Us
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
Pas-004 Tablets
Nf1 Mutation, Neurofibroma, Plexiform, Neurofibromatosis Type 1 (Nf1)-Related Plexiform Neurofibromas (Pns), Neurofibroma Plexiform, Neurofibromatosis Type 1 (Nf1)
Phase I
Recruiting
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
Apr 11, 2025
―
Pas-004 Capsules, Pas-004 Tablets
Advanced Solid Tumors, Ras Mutation, Raf Mutation, Nf1 Mutation
Phase I
Recruiting
PAS-004 in Patients With Advanced Solid Tumors
Feb 12, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pasithea Therapeutics Corp (KTTA) have in its pipeline
KTTA is currently developing the following drugs: Pas-004 Tablets, Pas-004 Capsules, Pas-004 Tablets. These drug candidates are in various stages of clinical development as the company works toward FDA approval.